Medico Remedies Limited has informed the Exchange regarding Appointment of Haresh Sanghvi as Other of the company w.e.f. April 01, 2025.
MEDICO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medico Remedies Limited announced audited financial results for FY25 and Q4, along with key governance changes at its board meeting held on May 8, 2025. Revenue from operations grew 4.2% YoY to Rs. 15,094.06 lakhs, while profit after tax rose 21.7% to Rs. 1,009.32 lakhs, and EPS improved to Rs. 1.22 from Rs. 1.00. Q4 FY25 PAT jumped ~40% YoY to Rs. 434.09 lakhs despite flat revenue. The board approved the cessation of VJ Shah & Co as statutory auditors upon completion of their term and appointed Shah Shroff & Associates for a 5-year period, subject to shareholder approval. Mr. Haresh Sanghvi was appointed as Secretarial Auditor for FY 2025-26 through FY 2029-30. The statutory auditor issued an unmodified opinion on the financial statements.
The results show healthy profit growth driven by margin expansion despite modest revenue growth, which is positive for shareholders. The auditor change is a routine rotation following term completion, not a governance red flag, so it should not affect investor confidence materially.